#RVTY

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

2 weeks ago

Stock index futures slide amid renewed tariff-related uncertainity (SPX:) Stock market futures slip as Trump raises tariffs to 15%, pressuring Dow, S&P; 500 and Nasdaq.

Stock index futures slide amid renewed tariff-related uncertainity

#spx #indu #us100:ind #glw #lly #rvty #pkg #tel #sw #us10y #us2y

Origin | Interest | Match

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

2 months ago

Stock index futures flat as traders await latest inflation data

#spx #us100:ind #indu #unp #rvty #ew #hii #cdw #sw #us10y #us2y

Origin | Interest | Match

Zerohero234

@zeroherovt.bsky.social

2 months ago

ok everyone we finally doing a RV there yet with @akehebo.bsky.social and @ashuogaming.bsky.social trying a make list for my top games for 2025 poyo!! Around 6:00pm pst www.twitch.tv/zerohero234 and youtube side too!! #Vtuber #RVTY

StockTitan

@stocktitan.net

2 months ago

#RVTY Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

www.stocktitan.net/news/RVTY/revvity-introd...

StockTitan

@stocktitan.net

4 months ago

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities Revvity, Inc., today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solutions for...

#RVTY Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

www.stocktitan.net/news/RVTY/revvity-to-acq...

StockTitan

@stocktitan.net

4 months ago

Revvity Announces Financial Results for the Third Quarter of 2025 The Company reported GAAP earnings per share of $0.40, as compared to $0.77 in the same period a year ago. Revenue for the quarter was $699 million, as compared to $684 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $82 million, as compared to $98 million for the same period a year ago.

#RVTY Revvity Announces Financial Results for the Third Quarter of 2025

www.stocktitan.net/news/RVTY/revvity-announ...

EarningsForesight

@earningsforesight.bsky.social

4 months ago

#Earnings to Watch - Week of Oct 27th, 2025
#BOH #CRI #DQ #KDP #RVTY #AGYS #AMKR #BBBY #CAR #CDNS #CFLT #CLS #CR #FFIV #NUE #NXPI #RMBS #UHS #V #CVNA #DAY #EBAY #FORM #GOOGL #KLAC #MELI #META #MSFT #CAH #CCCS #CMSA #COMM #CQP #CROX #DSGR #CVX #FET #GWW #IMO #LIN #LYB #MGA #NVT #RBC #TROW #XOM

StockTitan

@stocktitan.net

6 months ago

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina Revvity (NYSE:RVTY) has announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina's Research Triangle. The state-of-the-art facility consolidates R&D teams specializing in software, hardware, applied biology, machine learning, optical, microCT, and ultrasound technologies.The center showcases Revvity's latest innovations including the IVIS™ optical imaging systems, Quantum™ GX3 microCT system, Vega™ automated preclinical ultrasound system, and VivoJect™ Image-Guided Injection System. The facility aims to accelerate innovation in disease research workflows and advance next-generation imaging instruments while offering live demos and training opportunities for visitors.

#RVTY #PKI Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

www.stocktitan.net/news/RVTY/revvity-establ...

Market Wire News

@marketwirenews.com

7 months ago

News; ( NYSE: #RVTY ) Expected US Company Earnings on Monday, July 28th, 2025

Market Wire News

@marketwirenews.com

7 months ago

Just In: ( NYSE: #RVTY ) Expected earnings - Revvity Inc.

StockTitan

@stocktitan.net

7 months ago

Revvity Beats Q2 Expectations: Revenue Up 4% to $720M, Lifts Full-Year Outlook Revvity reports Q2 adjusted EPS of $1.18 with 3% organic growth. See raised full-year guidance and segment performance details. Get insights now.

#RVTY #PKI Revvity Announces Financial Results for the Second Quarter of 2025

www.stocktitan.net/news/RVTY/revvity-announ...

StockTitan

@stocktitan.net

9 months ago

New Cancer Testing Standards from Revvity Promise More Accurate Diagnostic Results for Oncology Labs Cell line-derived reference standards meet FDA requirements for cancer diagnostic testing. New Mimix controls enhance workflow monitoring and quality assurance. Learn more.

#RVTY #PKI Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

www.stocktitan.net/news/RVTY/revvity-introd...

StockTitan

@stocktitan.net

9 months ago

Revvity's New Automated Platform Transforms Specialty Disease Testing with 20-Analyte Capability Revolutionary IDS i20 platform processes 140 tests per hour across 6 disease specialties. Breakthrough automation for endocrinology and Alzheimer's testing. See capabilities.

#RVTY #PKI Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

www.stocktitan.net/news/RVTY/revvity-s-euro...

StockTitan

@stocktitan.net

11 months ago

Game-Changing TB Test: Revvity's New FDA-Approved System Cuts Testing Time by 70% Revolutionary automated TB testing platform processes 24 samples in 3.5 hours with superior accuracy. Enhanced reliability for immunocompromised patients. Full analysis inside.

#RVTY #PKI Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

www.stocktitan.net/news/RVTY/revvity-secure...

StockTitan

@stocktitan.net

11 months ago

Massive Breakthrough: Revvity's 100K Newborn Genetic Screening Program Targets 200 Rare Diseases Revvity expands Genomics England partnership, delivering end-to-end DNA sequencing for groundbreaking newborn screening study. Partnership aims to revolutionize early disease detection.

#RVTY #PKI Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

www.stocktitan.net/news/RVTY/revvity-expand...

StockTitan

@stocktitan.net

1 year ago

Groundbreaking Measles Test From Revvity Could Transform Diagnostics in Underserved Regions EUROIMMUN's innovative assay enables measles antibody detection from simple fingertip blood droplets, expanding testing access in regions with medical infrastructure.

#RVTY #PKI Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

www.stocktitan.net/news/RVTY/revvity-s-euro...

Blue Wave 🌊 2026•2028🗽

@jmzmuda.bsky.social

1 year ago

#Doge doesn’t seem to understand that delaying/cutting #NIH funding to Universities not only hurts Unis & American lives, but also wallstreet. Cutting NIH research will impact biotech company revenue & thus their stock.
#TMO #NYSE #BDX #ILMN #A #TMO #BIO #RVTY #WAT #QGEN #DHR #BRKR #MTD #CZMWY

StockTitan

@stocktitan.net

1 year ago

Court Ruling Locks In Revvity's Exclusive Control of Critical Spotfire Platform - What This Means for Research Markets Permanent injunction grants Revvity exclusive rights to Spotfire in research markets, strengthening market position and ensuring long-term customer support.

#RVTY #PKI Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

www.stocktitan.net/news/RVTY/revvity-wins-p...

StockTitan

@stocktitan.net

1 year ago

Revvity Crushes Q4 Expectations: Double-Digit Margin Growth Signals Major Turnaround Revvity delivers robust Q4 performance with 6% organic growth and improved margins. Company projects optimistic 2025 guidance with revenue up to $2.85B and adjusted EPS of $5.00.

#RVTY #PKI Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

www.stocktitan.net/news/RVTY/revvity-announ...

yogibearbull

@yogibearbull.bsky.social

1 year ago

WEEKEND BUSINESS DIGEST2
1/2 2025 Barron’s ROUNDTABLE Part 3. Recommendations this week were from Ahlsten, Giroux, Priest, Whitmer.
Todd AHLSTEN, Parnassus: #AMT, #DE, #KLAC, #LIN, #SNPS, #WDAY
David GIROUX, T Rowe Price: #BDX, #FTV, #PTC, #ROP, #RVTY, #TMO ...

StockTitan

@stocktitan.net

1 year ago

Revvity Announces Strong Q4 Revenue Growth, Expects to Beat 2024 EPS Guidance Revvity projects Q4 revenue of $730M with 6% organic growth, anticipating to meet or exceed full-year earnings guidance. Q4 and 2024 results to be released January 31.

#RVTY #PKI Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

www.stocktitan.net/news/RVTY/revvity-to-hol...

StockTitan

@stocktitan.net

1 year ago

Revvity Secures FDA Clearance for First-Ever Automated Free Testosterone Test Breakthrough automated ChLIA assay delivers direct free testosterone measurements in 48 minutes, revolutionizing diagnostics for hormonal disorders with 60 tests per hour capacity.

#RVTY #PKI Revvity Announces FDA Clearance for First Automated Free Testosterone Test

www.stocktitan.net/news/RVTY/revvity-announ...

StockTitan

@stocktitan.net

1 year ago

#RVTY #PKI Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

www.stocktitan.net/news/RVTY/revvity-broade...

StockTitan

@stocktitan.net

1 year ago

#RVTY #PKI Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

www.stocktitan.net/news/RVTY/scale-bioscien...

StockTitan

@stocktitan.net

1 year ago

#RVTY #PKI Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

www.stocktitan.net/news/RVTY/revvity-to-pre...

StockTitan

@stocktitan.net

1 year ago

#RVTY #PKI Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

www.stocktitan.net/news/RVTY/revvity-to-hos...

InsiderFinance

@insiderfinance.com

1 year ago

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #FFIE 59245.6x
2. #TUP 7556.6x
3. #CB 1450.8x
4. #EWCZ 132.0x
5. #RVTY 94.6x

#OptionFlow #OptionsTrading #Trading